Michael Weiss
37Patents
8h-index
15Co-inventors
72Inventor score
Filing activity: Mar 23, 1981 → Dec 27, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4477813A | Microstrip antenna system having nonconductively coupled feedline | Electricity | 55 | Expired |
| US4366484A | Temperature compensated radio frequency antenna and methods related thereto | Electricity | 39 | Expired |
| US4613868A | Method and apparatus for matched impedance feeding of microstrip-type radio frequency antenna structure | Electricity | 32 | Expired |
| US10822386B2 | Insulin analogues with enhanced stability and reduced mitogenicity | Human Necessities | 18 | Active |
| US5673774A | Auxiliary vehicle current collector | Performing Operations; Transporting | 11 | Expired |
| US8501440B2 | Fibrillation-resistant insulin and insulin analogues | Human Necessities | 10 | Active |
| US8716315B2 | Analogs of thalidomide as potential angiogenesis inhibitors | Chemistry; Metallurgy | 9 | Active |
| US7320991B2 | Analogs of thalidomide as potential angiogenesis inhibitors | Chemistry; Metallurgy | 8 | Expired |
| US8192957B2 | Fibrillation-resistant insulin and insulin analogues | Human Necessities | 8 | Active |
| US8993516B2 | Meal-time insulin analogues of enhanced stability | Human Necessities | 4 | Active |
| US9200053B2 | Insulin analogues containing penta-fluoro-Phenylalanine at position B24 | Human Necessities | 4 | Active |
| US9079975B2 | Insulin analogues with chlorinated amino acids | Human Necessities | 2 | Active |
| US10584156B2 | Insulin analogues with a glucose-regulated conformational switch | Emerging Cross-Sectional Technologies | 2 | Active |
| US8399407B2 | Non-standard insulin analogues | Human Necessities | 2 | Active |
| US8921313B2 | Halogen-stabilized insulin | Human Necessities | 2 | Active |
| US9487572B2 | Non-standard insulin analogues | Chemistry; Metallurgy | 2 | Active |
| US8343914B2 | Fibrillation resistant proteins | Human Necessities | 2 | Active |
| US9499600B2 | Long-acting single-chain insulin analogues | Human Necessities | 2 | Active |
| US9725493B2 | N-terminal truncated insulin analogues | Human Necessities | 2 | Active |
| US9388228B2 | Halogen-stabilized insulin | Human Necessities | 2 | Active |
| US10703792B2 | Insulin analogues with selective signaling properties and reduced mitogenicity | Human Necessities | 1 | Active |
| US9908925B2 | Ultra-concentrated rapid-acting insulin analogue formulations | Human Necessities | 1 | Active |
| US10138284B2 | Non-standard insulin analogues | Chemistry; Metallurgy | 1 | Active |
| US11174303B2 | Single-chain insulin analogues stabilized by a fourth disulfide bridge | Human Necessities | 1 | Active |
| US10561711B2 | Rapid action insulin formulations and pharmaceutical delivery systems | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.